In this issue:
Prognostic value of bronchiectasis in moderate-to-severe COPD
Lung microbiota and bacterial abundance in bronchiectasis
Low-dose erythromycin in non-CF bronchiectasis
Azithromycin maintenance in non-CF bronchiectasis
Long-term azithromycin for indigenous children with non-CF bronchiectasis
Inhaled ciprofloxacin dry powder in non-CF bronchiectasis
Inhaled colistimethate dry powder in CF
Lung clearance index response to ivacaftor in G551D-CFTR mutated CF
High-frequency chest wall oscillation vs. PEP mask in CF
Bronchiectasis risk factors in children with CF
Please login below to download this issue (PDF)